356 related articles for article (PubMed ID: 10937355)
21. Role of hepatic and lipoprotein lipase in lipoprotein metabolism and atherosclerosis: studies in transgenic and knockout animal models and somatic gene transfer.
Santamarina-Fojo S; Haudenschild C
Int J Tissue React; 2000; 22(2-3):39-47. PubMed ID: 10937353
[TBL] [Abstract][Full Text] [Related]
22. Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins.
Tornoci L; Scheraldi CA; Li X; Ide H; Goldberg IJ; Le NA
J Lipid Res; 1993 Oct; 34(10):1793-803. PubMed ID: 8245727
[TBL] [Abstract][Full Text] [Related]
23. A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease.
Kei AA; Filippatos TD; Tsimihodimos V; Elisaf MS
Metabolism; 2012 Jul; 61(7):906-21. PubMed ID: 22304839
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor.
Mann CJ; Troussard AA; Yen FT; Hannouche N; Najib J; Fruchart JC; Lotteau V; André P; Bihain BE
J Biol Chem; 1997 Dec; 272(50):31348-54. PubMed ID: 9395464
[TBL] [Abstract][Full Text] [Related]
25. [The important role of apolipoprotein C-III in lipoprotein metabolism].
Fruchart JC; Duriez P
C R Seances Soc Biol Fil; 1995; 189(5):889-97. PubMed ID: 8673634
[TBL] [Abstract][Full Text] [Related]
26. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
[TBL] [Abstract][Full Text] [Related]
27. An apolipoprotein(a) peptide delays chylomicron remnant clearance and increases plasma remnant lipoproteins and atherosclerosis in vivo.
Devlin CM; Lee SJ; Kuriakose G; Spencer C; Becker L; Grosskopf I; Ko C; Huang LS; Koschinsky ML; Cooper AD; Tabas I
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1704-10. PubMed ID: 15905467
[TBL] [Abstract][Full Text] [Related]
28. Role of apolipoprotein CIII in triglyceride-rich lipoprotein metabolism.
Fredenrich A
Diabetes Metab; 1998 Dec; 24(6):490-5. PubMed ID: 9932215
[TBL] [Abstract][Full Text] [Related]
29. In vitro catabolism of human very low density lipoproteins: fate of apoproteins B and C.
Catapano AL; Capurso A; Kinnunen PK
Artery; 1981; 9(2):87-95. PubMed ID: 7295047
[TBL] [Abstract][Full Text] [Related]
30. ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.
Gordts PL; Nock R; Son NH; Ramms B; Lew I; Gonzales JC; Thacker BE; Basu D; Lee RG; Mullick AE; Graham MJ; Goldberg IJ; Crooke RM; Witztum JL; Esko JD
J Clin Invest; 2016 Aug; 126(8):2855-66. PubMed ID: 27400128
[TBL] [Abstract][Full Text] [Related]
31. [The great Scandinavian Medical Jahre Prize 1994. Role of lipoprotein lipase in lipoprotein metabolism].
Olivecrona T
Nord Med; 1995; 110(1):4-8. PubMed ID: 7831108
[TBL] [Abstract][Full Text] [Related]
32. Lipoprotein analysis in transgenic mice expressing human apolipoprotein (apo) A-I and apo C III: use of micromethods in analysis of lipoprotein system in mice.
Ito Y
Hokkaido Igaku Zasshi; 1994 Mar; 69(2):312-26. PubMed ID: 8157256
[TBL] [Abstract][Full Text] [Related]
33. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
Khetarpal SA; Zeng X; Millar JS; Vitali C; Somasundara AVH; Zanoni P; Landro JA; Barucci N; Zavadoski WJ; Sun Z; de Haard H; Toth IV; Peloso GM; Natarajan P; Cuchel M; Lund-Katz S; Phillips MC; Tall AR; Kathiresan S; DaSilva-Jardine P; Yates NA; Rader DJ
Nat Med; 2017 Sep; 23(9):1086-1094. PubMed ID: 28825717
[TBL] [Abstract][Full Text] [Related]
34. Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C.
van Barlingen HH; de Jong H; Erkelens DW; de Bruin TW
J Lipid Res; 1996 Apr; 37(4):754-63. PubMed ID: 8732775
[TBL] [Abstract][Full Text] [Related]
35. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of human apolipoprotein C-III in transgenic mice results in an accumulation of apolipoprotein B48 remnants that is corrected by excess apolipoprotein E.
de Silva HV; Lauer SJ; Wang J; Simonet WS; Weisgraber KH; Mahley RW; Taylor JM
J Biol Chem; 1994 Jan; 269(3):2324-35. PubMed ID: 8294490
[TBL] [Abstract][Full Text] [Related]
37. Apolipoproteins C-I and C-III inhibit lipoprotein lipase activity by displacement of the enzyme from lipid droplets.
Larsson M; Vorrsjö E; Talmud P; Lookene A; Olivecrona G
J Biol Chem; 2013 Nov; 288(47):33997-34008. PubMed ID: 24121499
[TBL] [Abstract][Full Text] [Related]
38. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.
Jong MC; Hofker MH; Havekes LM
Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):472-84. PubMed ID: 10073946
[No Abstract] [Full Text] [Related]
39. Apolipoprotein C-II and C-III preferably transfer to both high-density lipoprotein (HDL)2 and the larger HDL3 from very low-density lipoprotein (VLDL).
Yamazaki A; Ohkawa R; Yamagata Y; Horiuchi Y; Lai SJ; Kameda T; Ichimura N; Tohda S; Tozuka M
Biol Chem; 2021 May; 402(4):439-449. PubMed ID: 33934596
[TBL] [Abstract][Full Text] [Related]
40. Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL.
Westerterp M; de Haan W; Berbée JF; Havekes LM; Rensen PC
J Lipid Res; 2006 Jun; 47(6):1203-11. PubMed ID: 16537968
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
